ProShare Advisors’s HUMANIGEN, INC. HGEN Stock Holding History

ProShare Advisors’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,662	Closed	-$40K	–	2329
2021 Q4	$40K	Buy	+10,662	New	+$62.4K	﹤0.01%	2307
2021 Q3	–	Sell	-11,636	Closed	-$202K	–	2340
2021 Q2	$202K	Buy	+11,636	New	+$212K	﹤0.01%	2141

Other funds holding HGEN

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ProShare Advisors's HGEN Position: Q1 2022 in Review

ProShare Advisors sold out of HUMANIGEN, INC. (HGEN) in Q1 2022, closing a stake of 10,662 shares — an estimated $40K sold.

ProShare Advisors first reported a position in HGEN in Q2 2021 and held it in 2 quarters. The position peaked at $202K in Q2 2021. 83 funds tracked by Wall St. Rank hold HGEN as of Q1 2022.

ProShare Advisors reported no remaining HUMANIGEN, INC. position as of Q1 2022 after selling out during the quarter.
ProShare Advisors sold 10,662 HUMANIGEN, INC. shares in Q1 2022, an estimated $40K.
ProShare Advisors first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 2 quarters.
ProShare Advisors's HUMANIGEN, INC. position peaked at $202K in Q2 2021.
83 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.